Clinical characteristics and outcomes of autoimmune pancreatitis based on serum immunoglobulin G4 levels: A single-center, retrospective cohort study

World J Gastroenterol. 2023 Dec 21;29(47):6161-6164. doi: 10.3748/wjg.v29.i47.6161.

Abstract

Autoimmune pancreatitis (AIP) is a complex, poorly understood disease gaining increasing attention. "Clinical Characteristics and Outcome of AIP Based on Serum IgG4 levels," investigated AIP with a focus on serum immunoglobulin (Ig) G4 levels. The 213 patients with AIP were classified according to serum IgG4 levels: Abnormal (elevated) and normal. Patients with higher IgG4 levels exhibited a more active immune system and increased relapse rates. Beyond IgG4, the IgA levels and age independently contributed to relapse risk, guiding risk assessment and tailored treatments for better outcomes. However, limitations persist, such as no IgA correlation with IgG4 levels, absent data on autoantibody-positive AIP cases critical for Asian diagnostic criteria, and unexplored relapse rates in high serum IgG AIP by subtype. Genetic factors and family histories were not addressed. As the understanding and referral of seronegative AIPs increase, there's a growing need for commercially available, highly sensitive, and specific autoantibodies to aid in diagnosing individuals with low or absent serum IgG4 levels.

Keywords: Autoimmune pancreatitis; Immune System, Immunoglobulin A; Immunoglobulin G; Outcomes; Relapse.

MeSH terms

  • Autoantibodies
  • Autoimmune Pancreatitis* / diagnosis
  • Humans
  • Immunoglobulin G
  • Recurrence
  • Retrospective Studies

Substances

  • Autoantibodies
  • Immunoglobulin G